Correlation Between Ascendis Pharma and BIONTECH

Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and BIONTECH at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and BIONTECH into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ascendis Pharma AS and BIONTECH SE DRN, you can compare the effects of market volatilities on Ascendis Pharma and BIONTECH and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of BIONTECH. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and BIONTECH.

Diversification Opportunities for Ascendis Pharma and BIONTECH

0.55

Correlation Coefficient

Ascendis Pharma  BIONTECH

Very weak diversification

The 3 months correlation between Ascendis and BIONTECH is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and BIONTECH SE DRN in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BIONTECH SE DRN and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with BIONTECH. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BIONTECH SE DRN has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and BIONTECH go up and down completely randomly.

Pair Corralation between Ascendis Pharma and BIONTECH

Assuming the 90 days trading horizon Ascendis Pharma AS is expected to generate 1.15 times more return on investment than BIONTECH. However, Ascendis Pharma is 1.15 times more volatile than BIONTECH SE DRN. It trades about 0.12 of its potential returns per unit of risk. BIONTECH SE DRN is currently generating about 0.05 per unit of risk. If you would invest  4,284  in Ascendis Pharma AS on September 13, 2024 and sell it today you would earn a total of  1,051  from holding Ascendis Pharma AS or generate 24.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Ascendis Pharma AS  vs.  BIONTECH SE DRN

Ascendis Pharma AS

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ascendis Pharma AS are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ascendis Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

BIONTECH SE DRN

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in BIONTECH SE DRN are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, BIONTECH may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Ascendis Pharma and BIONTECH

The main advantage of trading using opposite Ascendis Pharma and BIONTECH positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, BIONTECH can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BIONTECH will offset losses from the drop in BIONTECH's long position.

The idea behind Ascendis Pharma AS and BIONTECH SE DRN pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.